Is Coffee a Wise Adjunct to Hepatitis C Therapy?
In the debate over coffee's effect on health, coffee lovers who are undergoing treatment for Hepatitis C have just scored a victory.
Continue reading »Research & Treatment News
Share
Follow Us
Genetic Testing for Hep C Therapy Routine at Scripps Health
A California based health system will be one of the first to routinely order IL28B genotyping on all patients with Hepatitis C who are potential candidates for antiviral therapy.
Continue reading »Strides Made Towards Hepatitis C Preventative Vaccine
By utilizing a cold virus molecule, Danish researchers may have found a way to inoculate people against Hepatitis C.
Continue reading »No Health Insurance Equals No Hepatitis C Therapy
The disturbing health insurance gap in America leaves nearly two thirds of eligible Hepatitis C patients without access to treatment.
Continue reading »Hepatitis B and C Research Awarded Funds in Asia
Chinese and Indian researchers will receive nearly $1,000,000 from the Bristol-Myers Squibb Foundation to improve hepatitis awareness, prevention and care.
Continue reading »Do Home Remedies for Hepatitis C Work?
Feb 28, 2011
15 Comments
Determining if home remedies for Hepatitis C actually work depends on which remedies are being used and what the treatment goal is.
Continue reading »Hepatitis Awareness: 10 Liver Cancer Risks
Feb 28, 2011
1 Comment
To prevent having any controllable conditions that favor liver cancer development, this list of the most prevalent liver cancer risks is useful to those with chronic hepatitis.
Continue reading »Human Trials to Begin on Hepatitis C Drug
After encouraging pre-clinical studies, Medivir and Tibotec are beginning a Phase 1a trial of their Hepatitis C nucleoside inhibitor.
Continue reading »Immune Activation Repurposed for Developing Hepatitis C Therapy
Medical chemists from the UK are working on an oral Hepatitis C drug that works by activating a protein in the immune system.
Continue reading »Inhibitex's Hep C Drug Gets Fast-Tracked
As a result of the need for improved treatments, the FDA granted fast track development to INX-08189, a guanosine nucleotide polymerase inhibitor for treating Hepatitis C.
Continue reading »
